PriceTargets.com logo

PolarityTE - PTE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.00
  • Forecasted Upside: 23.46%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.81 As of 02/6/2023 01:00 AM ET
▲ +0.02 (2.53%)

This chart shows the closing price for PTE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PolarityTE Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PTE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PTE

Analyst Price Target is $1.00
▲ +23.46% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for PolarityTE in the last 3 months. The average price target is $1.00, with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 23.46% upside from the last price of $0.81.

This chart shows the closing price for PTE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in PolarityTE. This rating has held steady since December 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/8/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/7/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/6/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/28/2022Northland SecuritiesLower TargetOutperform$1.25 ➝ $1.00Low
3/30/2022Cantor FitzgeraldDowngradeOverweight ➝ NeutralHigh
11/10/2020Cantor FitzgeraldReiterated RatingOverweightLow
9/8/2020OppenheimerReiterated RatingHoldMedium
8/6/2020OppenheimerReiterated RatingHoldMedium
7/24/2020Northland SecuritiesReiterated RatingBuy$75.00High
5/12/2020HC WainwrightReiterated RatingHoldMedium
5/12/2020Cantor FitzgeraldLower TargetOverweight$225.00 ➝ $75.00Low
5/4/2020HC WainwrightDowngradeBuy ➝ NeutralHigh
4/30/2020OppenheimerDowngradeOutperform ➝ Market PerformHigh
4/27/2020HC WainwrightReiterated RatingBuy$125.00Medium
4/21/2020OppenheimerInitiated CoverageBuy$125.00High
4/8/2020Northland SecuritiesReiterated RatingBuy$200.00High
3/18/2020Cantor FitzgeraldReiterated RatingBuy$275.00High
12/5/2019Northland SecuritiesReiterated RatingBuy$500.00High
11/13/2019Piper Jaffray CompaniesLower TargetOverweight$650.00 ➝ $150.00High
11/13/2019HC WainwrightReiterated RatingBuy$200.00High
11/11/2019Cantor FitzgeraldLower TargetOverweight$1,250.00 ➝ $325.00High
10/18/2019Cantor FitzgeraldReiterated RatingOverweightHigh
10/11/2019Northland SecuritiesSet TargetBuy$500.00Low
9/23/2019Cantor FitzgeraldSet TargetBuy$1,250.00Medium
8/26/2019Northland SecuritiesSet TargetBuy$1,250.00High
8/21/2019OppenheimerSet TargetBuy$350.00N/A
8/20/2019Cantor FitzgeraldSet TargetBuy$1,250.00Low
8/9/2019OppenheimerLower TargetOutperform$600.00 ➝ $350.00Low
7/8/2019HC WainwrightInitiated CoverageBuy ➝ Buy$200.00High
5/13/2019National SecuritiesLower TargetSell$125.00 ➝ $75.00Low
5/10/2019Northland SecuritiesSet TargetBuy$1,250.00Low
4/8/2019Cantor FitzgeraldSet TargetBuy$1,625.00High
3/20/2019Evercore ISIInitiated CoverageOutperform ➝ Outperform$650.00High
3/19/2019Cantor FitzgeraldSet TargetBuy$1,625.00High
3/18/2019Piper Jaffray CompaniesSet TargetBuy$750.00High
3/18/2019Northland SecuritiesReiterated RatingBuy$1,250.00High
3/11/2019Northland SecuritiesReiterated RatingBuy$1,250.00Medium
1/29/2019OppenheimerInitiated CoverageOutperform$750.00Low
1/28/2019National SecuritiesInitiated CoverageSell ➝ Sell$125.00High
1/28/2019Northland SecuritiesInitiated CoverageOutperform ➝ Outperform$1,250.00Medium
1/14/2019Cantor FitzgeraldReiterated RatingBuy$1,625.00Medium
12/28/2018Cantor FitzgeraldSet TargetBuy$1,625.00Low
12/20/2018Piper Jaffray CompaniesInitiated CoverageOverweight ➝ OverweightHigh
10/15/2018Cantor FitzgeraldReiterated RatingBuy$1,625.00High
10/1/2018Cantor FitzgeraldReiterated RatingOverweightHigh
9/25/2018Cantor FitzgeraldReiterated RatingBuy$1,625.00Medium
(Data available from 2/7/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/12/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/11/2022
  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/10/2022
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/10/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/9/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/9/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/8/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/7/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
PolarityTE logo
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The firm operates through the following segments: regenerative medicine products and contract services. PolarityTE was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.
Read More

Today's Range

Now: $0.81
Low: $0.78
High: $0.81

50 Day Range

MA: $0.74
Low: $0.63
High: $0.83

52 Week Range

Now: $0.81
Low: $0.61
High: $13.00

Volume

15,856 shs

Average Volume

68,769 shs

Market Capitalization

$5.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Frequently Asked Questions

What sell-side analysts currently cover shares of PolarityTE?

The following Wall Street research analysts have issued stock ratings on PolarityTE in the last twelve months: Cantor Fitzgerald, and Northland Securities.
View the latest analyst ratings for PTE.

What is the current price target for PolarityTE?

1 Wall Street analysts have set twelve-month price targets for PolarityTE in the last year. Their average twelve-month price target is $1.00, suggesting a possible upside of 23.5%. Northland Securities has the highest price target set, predicting PTE will reach $1.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $1.00 for PolarityTE in the next year.
View the latest price targets for PTE.

What is the current consensus analyst rating for PolarityTE?

PolarityTE currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PTE will outperform the market and that investors should add to their positions of PolarityTE.
View the latest ratings for PTE.

What other companies compete with PolarityTE?

Other companies that are similar to PolarityTE include Windtree Therapeutics, Brickell Biotech, Fresh Tracks Therapeutics, TC Biopharm and Ayala Pharmaceuticals. Learn More about companies similar to PolarityTE.

How do I contact PolarityTE's investor relations team?

PolarityTE's physical mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company's listed phone number is (800) 560-3983 and its investor relations email address is [email protected] The official website for PolarityTE is www.polarityte.com. Learn More about contacing PolarityTE investor relations.